Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Cash from Operations (2016 - 2026)

Aytu Biopharma has reported Cash from Operations over the past 15 years, most recently at 3675000.0 for Q4 2025.

  • Quarterly Cash from Operations rose 26.51% to 3675000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 595000.0 through Dec 2025, down 188.41% year-over-year, with the annual reading at 1937000.0 for FY2025, 39.55% down from the prior year.
  • Cash from Operations was 3675000.0 for Q4 2025 at Aytu Biopharma, up from 618000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 9365000.0 in Q2 2023 and troughed at 9148000.0 in Q3 2022.
  • The 5-year median for Cash from Operations is 1190000.0 (2024), against an average of 2130842.11.
  • Year-over-year, Cash from Operations surged 2251.85% in 2024 and then tumbled 2441.34% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 8822000.0 in 2021, then surged by 72.21% to 2452000.0 in 2022, then surged by 94.49% to 135000.0 in 2023, then surged by 2251.85% to 2905000.0 in 2024, then grew by 26.51% to 3675000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Cash from Operations are 3675000.0 (Q4 2025), 618000.0 (Q3 2025), and 2803000.0 (Q2 2025).